Affiliation:
1. Russian Medical Academy of Continuing Professional Education;
Moscow City Ophthalmological Center, S.P. Botkin Hospital
2. Moscow City Ophthalmological Center, S.P. Botkin Hospital
Abstract
This review provides a detailed summary of the issues of etiology, pathogenesis and molecular mechanisms of corneal neovascularization. Signaling molecules involved in the process of neovasculogenesis, as well as their antagonists, antiangiogenic factors, are described. The role of signaling proteins VEGF, MMP and their receptors as modern targets of therapy is described on the basis of a series of clinical studies. The potentials of gene and bioengineering therapy as a promising method of treating corneal neovascularization are presented.
Reference64 articles.
1. Lee P, Wang CC, Adamis AP. Ocular Neovascularization. Survey of Ophthalmology. 1998; 43 (3): 245–69. doi: 10.1016/s0039-6257(98)00035-6
2. Gonz lez-Andrades M,. Garz n I, Gasc n MI, et al. Sequential development of intercellular junctions in bioengineered human corneas. J Tissue Eng Regen Med. 2009; (3): 442–9. doi: 10.1002/term.178
3. Qazi Y, Wong G, Monson B, Stringham J, Ambati BK. Corneal transparency: Genesis, maintenance and dysfunction. Brain Research Bulletin. 2010; 81 (2–3): 198–210. doi: 10.1016/j.brainresbull.2009.05.019
4. Oldman JN, Benedek GB. The relationship between morphology and transparency in the non-swelling corneal stroma of the shark. Invest Ophthalmology. 1967; 6 (6): 574–600.
5. Lim JJ. Na+ transport across the rabbit corneal epithelium. Curr Eye Res. 1981; 1 (4): 255–8. doi: 10.3109/02713688109001856